Molecular Pathways: Targeting Hsp90—Who Benefits and Who Does NotSCALTRITI, Maurizio; DAWOOD, Shaheenah; CORTES, Javier et al.Clinical cancer research (Print). 2012, Vol 18, Num 17, pp 4508-4513, issn 1078-0432, 6 p.Article

Expression of heat shock protein (Hsp) 70 and Hsp 40 in gastric cancerISOMOTO, Hajime; OKA, Mikio; UDONO, Heiichiro et al.Cancer letters. 2003, Vol 198, Num 2, pp 219-228, issn 0304-3835, 10 p.Article

Open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of intravenously administered CNF1010 (17-(allylamino)-17-demethoxygeldanamycin [17-AAG]) in patients with solid tumorsSAIF, M. W; ERLICHMAN, C; DRAGOVICH, T et al.Cancer chemotherapy and pharmacology. 2013, Vol 71, Num 5, pp 1345-1355, issn 0344-5704, 11 p.Article

Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: An orally bioavailable heat shock protein 90 modulatorKAUR, Gurmeet; BELOTTI, Dorina; BURGER, Angelika M et al.Clinical cancer research. 2004, Vol 10, Num 14, pp 4813-4821, issn 1078-0432, 9 p.Article

Altered distribution of heat shock protein 60 (Hsp60) with dysregulated expression of DHX32YONG CHEN; ALLI, Zaman; ACKERLEY, Cameron et al.Experimental and molecular pathology. 2007, Vol 82, Num 3, pp 256-261, issn 0014-4800, 6 p.Article

Heat shock protein 90 : A unique chemotherapeutic targetCULLINAN, Sara B; WHITESELL, Luke.Seminars in oncology. 2006, Vol 33, Num 4, pp 457-465, issn 0093-7754, 9 p.Article

A proteomic study on postdiapaused embryonic development of brine shrimp (Artemia franciscana)WEIWEI WANG; BO MENG; WEIHUA CHEN et al.Proteomics (Weinheim. Print). 2007, Vol 7, Num 19, pp 3580-3591, issn 1615-9853, 12 p.Article

Heat shock protein 70 in the rat nasal cavity: localisation and response to hyperthermiaSIMPSON, Sharon A; ALEXANDER, David J; REED, Celia J et al.Archives of toxicology. 2004, Vol 78, Num 6, pp 344-350, issn 0340-5761, 7 p.Article

Type 1 diabetes alters anti-HSP90 autoantibody isotypeQIN, Hui-Yu; MAHON, Jeffrey L; ATKINSON, Mark A et al.Journal of autoimmunity (Print). 2003, Vol 20, Num 3, pp 237-245, issn 0896-8411, 9 p.Article

A novel role for DYX1C1, a chaperone protein for both Hsp70 and Hsp90, in breast cancerYUXIN CHEN; MUZI ZHAO; JIANMIN LI et al.Journal of cancer research and clinical oncology. 2009, Vol 135, Num 9, pp 1265-1276, issn 0171-5216, 12 p.Article

High-throughput Screening Identifies Small Molecule Inhibitors of Molecular Chaperones : Molecular Chaperones as Drug TargetsKONDOH, Yasumitsu; OSADA, Hiroyuki.Current pharmaceutical design (Print). 2013, Vol 19, Num 3, pp 473-492, issn 1381-6128, 20 p.Article

Heat-shock protein 70 as a prognostic marker in node-negative breast cancerTHANNER, F; SÜTTERLIN, M. W; KAPP, M et al.Anticancer research. 2003, Vol 23, Num 2A, pp 1057-1062, issn 0250-7005, 6 p.Conference Paper

Hsp70 Protein Complexes as Drug Targets : Molecular Chaperones as Drug TargetsASSIMON, Victoria A; GILLIES, Anne T; RAUCH, Jennifer N et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 3, pp 404-417, issn 1381-6128, 14 p.Article

Antitumor Activity of SNX-2112, a Synthetic Heat Shock Protein-90 Inhibitor, in MET-Amplified Tumor Cells with or without Resistance to Selective MET InhibitionBACHLEITNER-HOFMANN, Thomas; SUN, Mark Y; SOLIT, David B et al.Clinical cancer research (Print). 2011, Vol 17, Num 1, pp 122-133, issn 1078-0432, 12 p.Article

Heat Shock Protein 90 Inhibition Depletes LATS1 and LATS2, Two Regulators of the Mammalian Hippo Tumor Suppressor PathwayHUNTOON, Catherine J; NYE, Monica D; LIYI GENG et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 21, pp 8642-8650, issn 0008-5472, 9 p.Article

Efungumab: A Novel Agent in the Treatment of Invasive CandidiasisKARWA, Rakhi; WARGO, Kurt A.The Annals of pharmacotherapy. 2009, Vol 43, Num 11, pp 1818-1823, issn 1060-0280, 6 p.Article

Characterization of the combined cellular survival effects of benzoquinone-ansamycins and ionizing radiationOCHEL, Hans-Joachim; GADEMANN, Gunther.Journal of cancer research and clinical oncology. 2005, Vol 131, Num 5, pp 323-328, issn 0171-5216, 6 p.Article

In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivativeHOLLINGSHEAD, Melinda; ALLEY, Michael; BURGER, Angelika M et al.Cancer chemotherapy and pharmacology. 2005, Vol 56, Num 2, pp 115-125, issn 0344-5704, 11 p.Article

Ganetespib and HSP90: Translating Preclinical Hypotheses into Clinical PromisePROIA, David A; BATES, Richard C.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 5, pp 1294-1300, issn 0008-5472, 7 p.Article

Targeting the molecular chaperone heat shock protein 90 (HSP90): Lessons learned and future directionsTONG, David S; BANERJI, Udai; TAVANA, Bahareh et al.Cancer treatment reviews. 2013, Vol 39, Num 4, pp 375-387, issn 0305-7372, 13 p.Article

Effect of ukrain on human lymphoma cell growth with different expressions of heat shock protein 70 (HSP70)ZHANAEVA, S. Y; KOROLENKO, T. A; SHILOV, A. G et al.International journal of immunotherapy. 2003, Vol 19, Num 2-4, pp 33-39, issn 0255-9625, 7 p.Article

Induction of neural differentiation by electrically stimulated gene expression of NeuroD2MIE, Masayasu; ENDOH, Tamaki; YANAGIDA, Yasuko et al.Journal of biotechnology. 2003, Vol 100, Num 3, pp 231-238, issn 0168-1656, 8 p.Article

HSP90 Inhibitor 17-AAG Selectively Eradicates Lymphoma Stem CellsNEWMAN, Bryan; YAN LIU; LEE, Hsiu-Fang et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 17, pp 4551-4561, issn 0008-5472, 11 p.Article

Stimulation of gastric ulcer healing by heat shock protein 70ISHIHARA, Tomoaki; SUEMASU, Shintaro; ASANO, Teita et al.Biochemical pharmacology. 2011, Vol 82, Num 7, pp 728-736, issn 0006-2952, 9 p.Article

Synergistic AntipancreaticTumor Effect by Simultaneously Targeting Hypoxic Cancer Cells With HSP90 Inhibitor and Glycolysis InhibitorXIANHUA CAO; BLOOMSTON, Mark; DUXIN SUN et al.Clinical cancer research. 2008, Vol 14, Num 6, pp 1831-1839, issn 1078-0432, 9 p.Article